Is it true that the price of Enasidenib in Hong Kong is 27,000?

Enasidenib is an oral targeted drug used to treat IDH2 mutant acute myeloid leukemia (AML). It is not currently available in China, so it is still not available for purchase directly in domestic pharmacies. This also means that the drug has not yet been included in the medical insurance catalog. If patients need treatment, they can only obtain relevant drugs through regular overseas channels or overseas pharmacies. Due to this situation, many patients have turned their attention to original drug channels in Hong Kong, Southeast Asia, Europe and the United States.

According to current market understanding, some pharmacies in Hong Kong do list Encidipine for approximately 27,000 yuan per box, and the specification is usually 50mg*30 tablets. This price is roughly consistent with the price of original drugs prevailing in the international market, and is even slightly lower than the prices quoted by some pharmacies in Europe and the United States. Therefore, the price of 27,000 yuan in Hong Kong pharmacies has a certain degree of authenticity. However, the price will be affected by many factors such as supply channels, currency exchange rates, and drug batches. Patients are advised to consult with multiple parties for confirmation before actually purchasing drugs.

It is worth noting that for patients with heavy financial burdens, there are also more affordable generic drug options in overseas markets. Currently, Lucius Pharmaceutical Factory in Laos has launched a generic version of Ensidipine, with the same specification of 50mg*30 tablets, and each box is sold for only about 1,000 yuan. This generic drug has been approved for marketing by the local drug regulatory department. The ingredients of the drug are basically the same as the original drug, and it has been used as an alternative treatment option by some patients. Although generic drugs are widely used around the world, it is still recommended that patients make judgments and choices under the guidance of a professional doctor before use.

Generally speaking, in the Hong Kong market27,000 a box of ensidipine is a relatively reasonable pricing range for the original drug. If the patient has the financial ability, choosing the original drug can provide clearer quality assurance; if the budget is limited, compliant generic drugs from Laos and other places can also be considered. No matter which version you choose, ensuring that drug channels are formal, safe and compliant is the most important prerequisite in the treatment process.

Reference materials:https://www.idhifa.com/